Is dutasteride stronger than finasteride?

Dutasteride blocks both Type I and Type II 5-alpha reductase, while finasteride blocks primarily Type II. At standard doses, dutasteride reduces serum DHT by roughly 90% compared to about 70% with finasteride. That pharmacologic difference tends to translate to somewhat greater hair count improvements in head-to-head studies, though the practical difference in many patients is modest.

Is dutasteride FDA-approved for hair loss in the United States?

No. In the U.S., dutasteride is FDA-approved only for benign prostatic hyperplasia (BPH). It is prescribed off-label for male pattern hair loss. Finasteride 1 mg is FDA-approved specifically for hair loss. Off-label is legal and routine, but your provider should counsel you on this distinction.

Can I switch from finasteride to dutasteride?

Yes. A common reason to switch is a partial or stalled response on finasteride after 12 or more months of consistent use. Clinicians typically confirm adherence, rule out other causes of shedding, and then transition. Dutasteride can be started directly after finasteride without a washout period.

Are the side effects of finasteride and dutasteride different?

Their side-effect profiles are very similar because both work on the same DHT pathway. Commonly reported effects include changes in libido, erectile function, and mood. Some studies suggest a slightly higher signal for sexual side effects with dutasteride, but head-to-head evidence is mixed and the absolute rates remain low for both drugs.

How long does dutasteride stay in your system after you stop?

Dutasteride has a terminal half-life of approximately four to five weeks, compared to roughly six to eight hours for finasteride. That means dutasteride's DHT-suppressing effect can persist for several months after the last dose. This matters if you want to stop treatment for any reason.

← Back to all articles

Men's Health · April 15, 2026 · 10 min read

Finasteride vs Dutasteride: Which Works Better for Hair Loss?

Finasteride and dutasteride are the two oral prescription medications proven to slow, stop, and in many men partially reverse androgenetic alopecia — the classic pattern of receding temples and crown thinning. They belong to the same drug class, they act on the same underlying hormone, and they produce broadly similar benefits. But they aren't interchangeable. One is FDA-approved for hair loss; the other is not. One clears your system in hours; the other in weeks. And their head-to-head trials tell a more interesting story than the marketing from either side. Here's an honest, evidence-based comparison for men deciding between them.

How Both Drugs Work

Androgenetic alopecia is driven by dihydrotestosterone (DHT), a potent androgen created when the enzyme 5-alpha reductase converts testosterone. In genetically susceptible hair follicles on the scalp, DHT binds to androgen receptors and gradually miniaturizes the follicle — each growth cycle produces a thinner, shorter hair until the follicle essentially shuts down. Block DHT at the scalp level, and that miniaturization slows. Block it more aggressively, and in many men it partially reverses.

There are two isoforms of 5-alpha reductase that matter here:

Type I is expressed mainly in sebaceous glands, skin, and liver.
Type II is the dominant isoform in hair follicles, prostate, and genital skin.

Finasteride is a selective Type II inhibitor. Dutasteride inhibits both Type I and Type II. That single pharmacologic distinction is the root of every other difference between the two drugs.

DHT Suppression: The Pharmacology in Plain Numbers

Serum DHT is the most commonly cited lab marker in the literature, and the numbers are fairly consistent across studies:

Finasteride 1 mg daily suppresses serum DHT by approximately 65–70%.
Dutasteride 0.5 mg daily suppresses serum DHT by approximately 90%.

On paper, that's a meaningful gap. Whether it translates to meaningfully better hair outcomes is the interesting question, and the answer is: somewhat, but less dramatically than the DHT numbers alone would suggest. Hair follicles have their own local concentrations of both enzyme isoforms, and scalp DHT does not map linearly to serum DHT. Still, in head-to-head studies, dutasteride tends to produce modestly higher hair counts.

The Evidence

Three pieces of the evidence base are worth knowing if you're making a decision:

The Olsen group (2006, expanded analysis 2016)

A randomized trial by Olsen and colleagues compared dutasteride 0.1, 0.5, and 2.5 mg against finasteride 5 mg and placebo in men with male pattern hair loss. Dutasteride 2.5 mg produced the largest hair count gains, but even the 0.5 mg dose — the standard BPH dose now commonly used off-label for hair loss — outperformed finasteride on scalp hair count and investigator-rated improvement. This trial is often cited as the clearest demonstration that dutasteride at 0.5 mg is, on average, modestly superior to finasteride for hair regrowth.

The Gupta meta-analysis (2014)

Gupta and Charrette pooled trials of 5-alpha reductase inhibitors for androgenetic alopecia. Their meta-analysis found dutasteride 0.5 mg produced significantly greater hair count increases than finasteride 1 mg at both 12 and 24 weeks, with adverse event rates that were not meaningfully different between the two drugs at standard doses.

The Cochrane review (2024)

A 2024 Cochrane systematic review of pharmacologic interventions for androgenetic alopecia reaffirmed that both finasteride and dutasteride produce statistically significant improvements in hair count and patient-rated outcomes versus placebo, with moderate-certainty evidence favoring dutasteride for greater magnitude of response. The review also emphasized the relative scarcity of long-term (5+ year) safety data for dutasteride in a hair-loss population, since its approved indication is BPH.

"Dutasteride at 0.5 mg/day demonstrated superiority over finasteride 1 mg/day for hair count at week 24, with a mean difference of approximately 17 hairs per cm² in a representative target area."— Olsen et al., Journal of the American Academy of Dermatology, 2006

Side-by-Side Comparison

Feature	Finasteride	Dutasteride
Brand names	Propecia, Proscar	Avodart
Mechanism	Blocks Type II 5-AR	Blocks Type I and II 5-AR
Hair loss dose	1 mg daily	0.5 mg daily (off-label)
Serum DHT suppression	~65–70%	~90%
Half-life	6–8 hours	4–5 weeks
FDA status (hair loss)	Approved	Off-label
FDA-approved indication	Hair loss, BPH	BPH only (U.S.)
Decades on market	Since 1997 (hair)	Since 2001 (BPH)
Generic cost (cash-pay)	$15–$30/month	$20–$40/month
Typical use in practice	First-line	Non-response or aggressive loss

Side Effects: Practically Similar, With Nuances

Because both drugs lower DHT, their side-effect profiles overlap almost entirely. The reported effects in clinical trials and post-marketing surveillance include:

Decreased libido (1–3% across studies)
Erectile dysfunction (1–2%)
Ejaculatory volume reduction or decreased semen
Breast tenderness or gynecomastia (uncommon)
Mood changes, including depressive symptoms in a subset of users
Prostate-specific antigen (PSA) reduction of roughly 50% — your clinician should know you're on the drug when interpreting PSA

A few studies — notably some post-marketing European dutasteride analyses — have suggested a slightly higher numerical rate of sexual side effects on dutasteride than finasteride. Others, including the Olsen trial and several meta-analyses, found no statistically significant difference. The honest summary is: at standard doses, the drugs are very similar in tolerability, and there's no strong signal that one is dramatically safer than the other.

A separate question is post-finasteride syndrome, a cluster of persistent sexual, mood, and cognitive complaints reported by a subset of men after stopping the drug. The phenomenon remains controversial — mechanism is unclear, causality is difficult to prove in observational data, and large epidemiologic cohorts have not reliably reproduced it. Whether it's a rare but real adverse effect or a phenotype that existed before treatment is still debated in the dermatology and urology literature. For most men, clinical side effects resolve after stopping the drug.

The Half-Life Difference Matters More Than People Think

Finasteride clears your system in a day or two; dutasteride lingers for months. The terminal half-life of dutasteride is about four to five weeks, meaning it takes roughly four to five months for the drug to fully wash out after the last dose. Practical implications:

If you develop a side effect on dutasteride and stop, DHT suppression does not end quickly. Symptoms may persist for weeks to months.
If you're planning to conceive, dutasteride is present in semen. The FDA recommends avoiding blood donation for at least six months after the last dose of dutasteride, and pregnant partners should not handle broken tablets. Finasteride's shorter half-life makes these precautions shorter.
Missing a dose matters less with dutasteride — steady-state plasma concentrations are much more forgiving of an occasional skipped pill.

For men who like the idea of being able to stop a medication and "undo" it quickly, finasteride is the more flexible choice.

Who Should Start With Which?

Finasteride is usually the better starting point if:

You've never taken a 5-alpha reductase inhibitor
Your hair loss is mild to moderate (Norwood 2–4)
You want the shorter half-life in case you need to stop
You want a medication that's FDA-approved for your specific use
Cost is a priority (generic finasteride is modestly cheaper)
You may want to father children in the next year

Dutasteride may be a better fit if:

You've taken finasteride consistently for 12+ months with inadequate response
You have more advanced hair loss (Norwood 5+) and want the strongest available oral DHT blocker
You also have lower urinary tract symptoms from BPH — dutasteride treats both
You've accepted that it's an off-label use in the U.S. and are comfortable with longer drug exposure

This tiered approach — finasteride first, then dutasteride for non-responders — is what most dermatology and urology guidelines recommend, and it's how most evidence-based telehealth practices (including Bidwell) structure their hair-loss plans.

Switching and Combining

If you've been on finasteride for a full year with disappointing results, switching directly to dutasteride is reasonable. No washout is required — you can stop finasteride one day and start dutasteride the next. Expect the evaluation of response to reset: budget another 6–12 months before judging whether dutasteride is doing more for you.

Combining 5-alpha reductase inhibitors with minoxidil (topical or low-dose oral) adds a second, independent mechanism — follicular vasodilation rather than DHT suppression — and the combination consistently outperforms either drug alone in clinical trials. Most modern hair-loss regimens use a 5-ARI plus minoxidil for that reason.